Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and

Marianne Benn1, Gerald F Watts, Anne Tybjaerg-Hansen

  • 1Chief Physician, Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark.

Insights

Familial hypercholesterolemia (FH) affects 1 in 137 people, significantly increasing coronary artery disease risk. Many FH patients remain undiagnosed or undertreated, highlighting a critical public health issue.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Epidemiology

Background:

  • Familial hypercholesterolemia (FH) diagnosis relies on clinical criteria including personal/family history of premature cardiovascular disease and hypercholesterolemia, alongside genetic confirmation of low-density lipoprotein receptor (LDLR) or apolipoprotein B (APOB) gene mutations.
  • The Dutch Lipid Clinic Network criteria are a standard diagnostic tool for FH.

Purpose of the Study:

  • To determine the prevalence of FH in an unselected Danish population.
  • To investigate the association between FH and coronary artery disease (CAD).
  • To assess the use of cholesterol-lowering medication in individuals with FH.

Main Methods:

  • The Copenhagen General Population Study included 69,016 unselected, community-based participants.
  • FH was defined using the Dutch Lipid Clinic Network criteria (score > 5).
  • Coronary artery disease (CAD) was defined as myocardial infarction or angina pectoris.

Main Results:

  • The prevalence of definite/probable FH was 0.73% (1 in 137 individuals).
  • Twenty percent of FH participants had a pathogenic LDLR or APOB mutation.
  • FH was associated with a significantly elevated risk of CAD (OR 13.2 off medication, OR 10.3 on medication), even when treated.
  • Only 48% of FH individuals reported taking cholesterol-lowering medication.

Conclusions:

  • The prevalence of FH in the Danish general population is higher than previously estimated.
  • A substantial proportion of individuals with FH are undiagnosed or undertreated, leading to a high burden of CAD.
  • There is a critical need for improved community and primary care strategies for FH diagnosis and management.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...